SEC Form 4 · accession 0001104659-17-062531
Neos Therapeutics, Inc. · NEOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vipin K Garg
Officer — Chief Executive Officer · Director
Period of report
Oct 16, 2017
Accepted (ET)
Oct 17, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 16, 2017 | F | 14,895 | $8.00 | D | 135,748 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock.